Next Article in Journal
Prognostic Implication of Preoperative Anemia in Redo Cardiac Surgery: A Single-Center Propensity-Matched Analysis
Next Article in Special Issue
Trigger and Substrate Mapping and Ablation for Ventricular Fibrillation in the Structurally Normal Heart
Previous Article in Journal
Impella Versus VA-ECMO for Patients with Cardiogenic Shock: Comprehensive Systematic Literature Review and Meta-Analyses
Previous Article in Special Issue
Impact of Systematic Use of Intracardiac Ultrasound during Transseptal Catheterization in the Electrophysiology Laboratory
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Moderator Band and Ventricular Tachycardia: Structural or Functional Substrate?

by
Federico Landra
1,†,
Carmine Marallo
1,†,
Amato Santoro
2,
Simone Taddeucci
1,
Maria Cristina Tavera
3,
Claudia Baiocchi
2 and
Alberto Palazzuoli
3,*
1
Division of Cardiology, Department of Medical Biotechnologies, University of Siena, 53100 Siena, Italy
2
Division of Cardiology, Cardio Thoracic and Vascular Department, Azienda Ospedaliera Universitaria Senese, 53100 Siena, Italy
3
Cardiovascular Diseases Unit, Cardio Thoracic and Vascular Department, Azienda Ospedaliera Universitaria Senese, University of Siena, 53100 Siena, Italy
*
Author to whom correspondence should be addressed.
These authors contributed equally to this work.
J. Cardiovasc. Dev. Dis. 2023, 10(4), 159; https://doi.org/10.3390/jcdd10040159
Submission received: 15 March 2023 / Revised: 29 March 2023 / Accepted: 3 April 2023 / Published: 6 April 2023
(This article belongs to the Special Issue Modern Approach to Complex Arrhythmias)

Abstract

:
The moderator band (MB) is an intracavitary structure of the right ventricle composed of muscular fibers encompassing specialized Purkinje fibers, separated each other by collagen and adipose tissue. In the last decades, premature ventricular complexes originating within the Purkinje network have been implicated in the genesis of life-threatening arrhythmias. However, right Purkinje network arrhythmias have been much less reported in the literature compared to the left counterpart. The MB has unique anatomical and electrophysiological properties, which may account for its arrhythmogenicity and may be responsible for a significant portion of idiopathic ventricular fibrillation. MB embodies autonomic nervous system cells, with important implications in arrhythmogenesis. Some idiopathic ventricular arrhythmias, defined as the absence of any identifiable structural heart disorder, can begin from this site. Due to these complex structural and functional peculiarities strictly interplayed each other, it is arduous to determine the precise mechanism underlying MB arrhythmias. MB-related arrhythmias should be differentiated from other right Purkinje fibers arrhythmias because of the opportunity for intervention and the unusual site for the ablation poorly described in the literature. In the current paper, we report the characteristics and electrical properties of the MB, their involvement in arrhythmogenesis, clinical and electrophysiological peculiarities of MB-related arrhythmias, and current treatment options.

1. Introduction

Moderator band (MB) related ventricular tachycardias (VTs) and premature ventricular contractions (PVC) are being increasingly recognized as a cause of idiopathic VTs. The MB is a muscular structure extending from the anterior septum to the anterior papillary muscle (APM) of the right ventricular (RV) free wall. This structure comprises a specialized Purkinje fibers network which allows for rapid activation of the RV-free wall [1]. The MB is composed of muscular fibers encompassing specialized Purkinje fibers, separated from the surrounding muscular cells by collagen and adipose tissue. Additionally, it is highly innervated by autonomic nervous system elements [2], with important implications in arrhythmogenesis. Idiopathic ventricular arrhythmias, defined by the absence of any identifiable structural heart disease or genetic arrhythmic disorder, have usually been considered “benign” in terms of prognosis [3]. Nonetheless, in the last decades, short coupling PVCs [4] e and PVCs originating within the Purkinje network have been described as a trigger of life-threatening arrhythmias and characterization and treatment of such idiopathic ventricular arrhythmias have become increasingly investigated [5,6,7]. After the development of sophisticated imaging tools such as intracardiac echocardiography (ICE) and intracardiac mapping, MB has been increasingly recognized as a source of short-coupling PVCs, VTs, and idiopathic ventricular fibrillation (IVF); [8,9]. The arrhythmogenic potential of MB involves multiple mechanisms due to the peculiar anatomical and electrical properties of this structure. Purkinje fibers may initiate arrhythmias by different mechanisms, mainly enhanced automaticity, trigger activity, and re-entry [10]. Sustained VTs are instead supported by a reentrant mechanism, favored by the action potential duration (APD) gradient established between MB and RV, and can be treated by catheter ablation [11].

2. Anatomy of the Moderator Band

The MB is an intracavitary structure of the RV which spans from the interventricular septum (IVS) to the RV-free wall at the base of the APM, and it is considered part of the septomarginal trabeculation. The MB has high interindividual variability in terms of origin and shape [12]. It might originate from the supraventricular crest to the ventricular apex, with single or double roots. Moreover, it can be classified into three major types according to its shape: cylindrical column (type 1), long and thin column (type 2), and wide and flat column (type 3) [13]. The most common configuration of MB is a single root origin from the middle IVS with a type 2 shape.
Originally described by Leonardo Da Vinci, the MB takes its name from what it was thought to be its function, which is to prevent RV excessive distension thanks to the anatomic link of the IVS and RV free wall. Later, it was found that part of the right half of the Purkinje system is contained in the MB, allowing for synchronous activation of the RV-free wall during systole. The right Purkinje system is composed of the right bundle branch (RBB), the free-running Purkinje fibers (PF), which branch from the RBB along its length, and the terminal PF, which connects with the free-running PF in the parietal RV wall. The terminal PF account for the largest part of the right Purkinje network, forming a more complex network than that in the left ventricle that cover the majority of the RV free wall and extends toward the tricuspid valve [12]. PF spreads across the IVS through the MB, becomes more superficial in the distal third of the MB, and finally joins the APM to the RV-free wall, forming the subendocardial ventricular plexus.
PF are a longitudinal assembly of Purkinje cells (PC) and are insulated from working myocytes by a connective tissue sheath that is lost before the PF form the terminal connections with the working myocytes through specialized junctions in the endocardium [14,15]. Recently, Walton et al. [11] demonstrated that the MB has a compartmentalized structure between the myocardium and PF, which have a coaxial configuration separated each other by a layer of collagen and lipid droplets that provide electrical insulation. Therefore, the MB is formed by these two excitable yet electrically uncoupled compartments.
The MB vasculature is perfused by the anterior interventricular coronary artery and the right coronary artery from the base of the APM, forming an important collateral circulation between the left and right coronary artery systems [1].
Innervation of the MB is supplied by elements of the autonomic system, being the PF more sensible to the parasympathetic neurotransmitter acetylcholine (ACh) compared to ventricular muscle because of a higher expression of channels responsible for IKACh current [2,16].

3. Electrical Properties of the Moderator Band

PC are specialized myocardial cells that are responsible for the synchronous activation of the ventricles. Ion channel expression substantially differs from that of the working myocites and can explain the specialized electrical activity of the PC [12]. Differently from working myocardium, PC are poorly contractile and, therefore, have a lower expression of Ca2+-handling proteins such as RYR2 (Ryanodine receptor 2), RYR3 (Ryanodine receptor 3), SERCA2a (sarcoplasmatic/endoplasmic reticulum Ca2 ATPase 2a), and NCX (Na+-Ca2+ exchangers). In contrast, they are fast conducting because of high upstroke velocity during phase 0 of action potential and high conduction velocity. These properties are explained by a higher expression of Na+ channels, particularly Na1.1, and of the fast-conducting connexin Cx40. Regarding the K+ channel profile, PC show a lower expression of Kv1.4 and a higher expression of Kv4.2, the first being a slow recovering isoform while the second being a fast one, both responsible for Ito (transient outward current). On the other hand, the K+ conductance involved in phase 2 and phase 3, namely IKs, IKr, and IKur (for whom KvLQT1, ERG, and Kv1.5 are responsible, respectively), are predicted to be lower in PC as compared to working myocardium. In addition, the IK1 current generated by the Kir2 channels family (Kir2.1–2.4) responsible for the maintaining of resting potential is less represented in PC, and HCN 1 and HCN4, which underlie If current, are more expressed. All these differences account for the following differences in action potential: high upstroke velocity during phase 0, a prominent early rapid repolarization (phase 1), a negative potential plateau (phase 2), an increased APD, and a spontaneous diastolic depolarization (phase 4), which is normally inapparent because of overdrive suppression by the sinus node. Additionally, it has been shown that genetically determined upregulation of the DPP6 (dipeptidyl aminopeptidase-like protein 6) gene, which encodes for a beta subunit of Kv4 channels, enhances Ito in PF with consequent strong repolarization gradient between the PF and the adjacent ventricular myocardium, with possible phase 2 re-entry induced PVCs [17].
Moreover, the electrophysiological properties of MB may be influenced by its anatomic variability [11]. Particularly, variability of thickness and muscle/PFs ratio may be associated with a reduction of the effective refractory period, which is sensitive to tissue mass and coupling. Many factors may as well affect the dispersion of refractoriness within the myocardial syncytium represented by the MB, such as mechanical stretch (i.e., RV overload, bradycardia, conditions that induce a prolongation of APD; [18] and cardiac autonomic nervous system modulation [19]. These features may explain the ECG morphologies of PVC (Figure 1).

4. Moderator Band-Related Arrhythmias

4.1. Arrhythmogenic Mechanisms

All arrhythmogenic mechanisms may be involved in the genesis of MB-related arrhythmias, particularly triggered activity and re-entry. PF are often involved in the genesis of ventricular arrhythmias due to their susceptibility to the development of early afterdepolarizations (EADs). EADs seem to be ascribable mainly to inward calcium currents (L-type Ca2+) but also to late Na+ currents during late phase 2/early phase 3 of the action potential. Moreover, PVCs may originate from a phase 2 re-entry because of the strong repolarization gradient between the two compartments of the MB [20,21]. A critical number of cells exhibiting afterdepolarizations in a synchronous manner is essential to generate arrhythmias at the organ dimension. The susceptibility of the RV-free wall-MB junction to generate short-coupling PVCs may be related to the mechanical strain of the MB during proto-diastole, a “mechanoelectrical feedback” phenomenon that may induce ion channel activation [22].
Short-coupled PVCs originating in the proximal MB may determine a unidirectional conduction block within the myocardial compartment of the MB and consequently induce a sustained monomorphic VT through a macro re-entry circuit. The Purkinje network must overcome the large source-sink mismatch where it couples with the myocardium. The high density of Na+ channels is essential to provide sufficient safety factors for conduction. Moreover, a transitional layer of cells serves to amplify impulses and shield the Purkinje network from electrotonic loading. The wavefront propagates from the IVS to the RV-free wall and then activates it both in basal and apical directions. While the apical wavefront collides at the MB root with the repolarization wave tail, the basal propagation front encounters excitable tissues of the IVS, sufficiently delayed to allow the circuit completion. The demonstration of the involvement of these structures in the re-entry circuit has been provided by the experiment conducted by Walton et al. that showed the interruption of the macro reentry circuit after severing the MB in a sheep heart during sustained VT [11].
Additionally, polymorphic VT, like torsades de pointes, may result from a meandering or drifting spiral wave propagation. Both monomorphic and polymorphic VT, when an electrical or structural obstacle is encountered, may eventually degenerate into ventricular fibrillation (VF) because multiple spiral waves break up with the consequent genesis of daughter spirals. MB-related VF still represents a rare but not neglectable percentage of IVF [23]. Some case series described a VT and VF related to early coupled PVC originating from the MB [8]. Short coupled torsade de point (sc-TdP) should be classified as idiopathic VF from PF.
Furthermore, 3D-mapping and intracardiac echocardiography showed that sc-TdP predominantly originated from MB free wall and its PF network [24].

4.2. Right Purkinje Network Arrhythmias: In Addition to the Moderator Band

As mentioned, the right Purkinje system is composed of the RBB, free-running PF, and terminal PF, which form a complex network at the RV free wall extending up to the tricuspid valve (TV); [12]. The electrophysiological properties of the PC, which intrinsically justify a proarrhythmic behavior, may theoretically result in arrhythmias originating at each level of the complex right Purkinje network. However, right Purkinje network arrhythmias and their potential deleterious consequences have been less reported in the literature. Therefore, MB-related arrhythmias should be differentiated from other right-sided PF arrhythmias, such as those from APM and TV. VTs originating at the APM level seem to be provokable by isoproterenol or burst pacing, suggesting triggered activity as the underlying mechanism [25]. Moreover, the inability to entrain VTs from APM or terminate them by overdrive pacing supports automaticity instead of re-entry as a potential inducible mechanism.
The electrocardiographic (ECG) analysis may help clinicians in hypothesizing these specific arrhythmias. MB-related arrhythmias are typically classified among those with a superior axis configuration, such as those from inferior TV and left posterior fascicles [26,27,28] (Figure 1). Typically, MB-related arrhythmias have a left superior axis (positive D1 and negative DII/DIII) and late precordial transition (later than V4), similar to those originating from APM [29]. Sometimes, DII/DIII discordance may be observed, such as for lateral TV and para-Hissian origins. TV arrhythmias may display a variable precordial transition depending on the more septal or lateral origin (from V2 to V5) for those with a superior axis. On the contrary, left posterior fascicle arrhythmias usually mimic a typical RBB pattern with rsR’ and specifically have a QRS < 130 ms because of the rapid ventricular depolarization through the Purkinje system.
Sometimes monomorphic VTs may sustain through a re-entry circuit involving both the right and left bundle branches (called bundle branch re-entry), a single left fascicle (intrafascicular re-entry), or both left fascicles (interfascicular re-entry). However, the intrafascicular re-entry has not been demonstrated at the right Purkinje system level yet. Bundle branch re-entry VTs are often observed in patients with acquired heart disease, which might involve the His-Purkinje system, and, therefore, would lead to slow conduction within the Purkinje system necessary for the occurrence of re-entry. However, conduction disturbances in the His-Purkinje system of young patients with structurally normal hearts can also lead to susceptibility to bundle branch reentry VTs [30]. Finally, MB could be involved in atrioventricular reciprocating arrhythmias due to the insertion of an accessory pathway (Mahaim fascicles) into the PF of the MB.

5. Diagnostic of Moderator Band Related Tachycardia

5.1. Initial Evaluation

Patients may have a high variability of clinical presentation, ranging from isolated PVCs, either symptomatic or asymptomatic, to electrical storm and cardiac arrest. Most of the cases of MB-related arrhythmias have been described in middle-aged males. The actual prevalence of these arrhythmias is unknown because of a lack of reports in the literature, and described cases are usually those who have experienced a major event such as cardiac arrest [9].
The initial evaluation of patients presenting with an arrhythmic event does follow the generic algorithm proposed by the latest ESC guidelines on ventricular arrhythmias and sudden cardiac death until a specific diagnosis is reached [23]. Patients with symptomatic or asymptomatic (incidental finding) PVCs/non-sustained ventricular tachycardia (NSVT) should undergo a thorough evaluation which starts from PVCs/NSVT analysis (morphology, coupling interval, burden, cycle length in case of NSVT, relation with physical stress), and covers personal history (cardiovascular risk factors, symptoms such as palpitations, dyspnea, angina and syncope, comorbidities and medications), family history (sudden cardiac death, primary electrical disease, cardiomyopathy), and laboratory tests. In case of arrhythmic syncope, fast monomorphic NSVT, or short coupled PVC followed by polymorphic NSVT, the patients should be admitted to the hospital, and subsequent evaluation performed during hospital admission; otherwise, an ambulatory evaluation is sufficient [23]. On the other hand, patients presenting with a first episode of sustained ventricular tachycardia (SVT) should be similarly evaluated, but hospital admission is mandatory because of the risk of major arrhythmic events. In these cases, the ECG analysis could be particularly helpful in determining the site of origin of PVC/NSVT and, as mentioned above, MB-related arrhythmias usually display a left superior axis (positive D1 and negative DII/DIII) and late precordial transition (later than V4), but may also present with a DII/DIII discordance [4,9].
On the contrary, in patients presenting with a cardiac arrest, usually, a complete ECG documentation of the arrhythmic event is unavailable; hence, it may initially remain unknown the involvement of the MB in the genesis of PVC triggers. Therefore, those patients who survive the event should be evaluated with the aim of excluding the ischemic etiology or other structural heart diseases, primary electrical diseases, metabolic or toxic causes, and extracardiac causes through brain and chest CT scan [17,26].

5.2. Diagnostic Tests

First-line testing for patients presenting with PVCs/NSVT/SVT includes a 12-lead ECG, a complete echocardiogram, and at least 24 h continuous ECG monitoring (Holter ECG in ambulatory setting). When there is suspicion of an underlying coronary artery disease or structural heart disease, coronary angiography and/or cardiac magnetic resonance should be performed. Otherwise, if a primary electrical disease is suspected, further evaluation should be considered, such as a genetic test, exercise test, and sodium channel blocker test. However, patients with moderator band-related arrhythmias usually show negative results of the abovementioned examinations; therefore, the arrhythmic events are to be labeled as idiopathic. Symptomatic patients with idiopathic PVCs/VTs could be subsequently referred for catheter ablation or treated with drug therapy, whereas asymptomatic patients with a high burden of PVCs (>10%) should undergo a regular follow-up and optionally be referred for catheter ablation [23,26].
Similarly, sudden cardiac arrest survivors in whom all diagnostic examinations have failed to provide a diagnosis should be labeled as IVF. In this case, it is important not to miss the opportunity to perform comprehensive clinical testing (sudden cardiac death family history, personal medical history, ECG, exercise test, and echocardiogram) of first-degree family members to prevent sudden cardiac death. In patients who have experienced IVF, an ICD implantation is mandatory, but the involvement of the MB in the genesis of PVCs that may trigger VF can remain ignored until further events occur or catheter ablation of PVC triggers is considered [31].

6. Management of Moderator-Band Ventricular Tachycardias

6.1. Ablation Targets

Radiofrequency (RF) catheter ablation seems to be an effective approach in the treatment of MB-related arrhythmias. Several case reports have shown good results in suppressing PVCs-mediated VF and electrical storms [8,9]. An electro-anatomic map merged with intracardiac ultrasound images is fundamental to correctly identify, localize and treat arrhythmic foci located in the right Purkinje network (Figure 2). PF potential, represented by a sharp, short-lasting, high-frequency potential, is often the earliest potential recorded before the onset of the PVCs (Figure 3). Ablation performed targeting PF potentials was often successful in suppressing PVCs-mediated VF. The most frequent site of origin of VF/VT trigger was the left-sided PF, followed by the outflow tract region and MB. The role of PF in the genesis of VT/VF has been well described, with the targeting of the earliest pre-QRS PF potential [8].
The anatomic variability of the MB could account for multiple PF-mediated PVCs morphology. Therefore, multiple sites of ablation, of which the whole MB, its insertion in the RV free wall and IVS and the APM, have to be considered in order to completely eliminate the PVCs source, even though it has been reported that ablation at the earliest PF potential recorded is generally effective in suppression of PVCs aside from their morphology [32,33].
Complete ablation of the MB and of its insertion points in the right ventricle is fundamental also to interrupt the macro re-entry circuit. Using contact force-sensing catheters with vector analysis in addition to ICE is fundamental to guarantee sufficient contact and stability of the catheter tip to the ablation site, as well as using higher RF energy. Cryoablation may configure a therapeutic option to achieve arrhythmic substrate disappearance and effective MB ablation [8,31].

6.2. Pharmacological Therapy

There is a lack of strong evidence concerning the pharmacological management of MB-related arrhythmias. Nonetheless, since PF are the most likely trigger for arrhythmias, it seems reasonable to manage them as usual for idiopathic VF. Quinidine has been reported to be effective in suppressing PVCs arising from the Purkinje network, considering its ability to suppress the Ito. Haissaguerre and colleagues demonstrated that repetitive activity from the distal PF network may cause VF even with minimal or no PVCs at baseline. Quinidine is a class Ia sodium channel blocker that also reduces the potassium currents IK1 and IKto. This combined effect may make quinidine uniquely effective in controlling arrhythmias associated with action potential duration dispersion and phase 2 reentry, postulated in IVF. Particularly, Ito is highly expressed in PF, possibly explaining the unique effect of quinidine. Several studies have demonstrated a reduced incidence of ventricular arrhythmias in patients with IVF treated with quinidine. The transient outward potassium current Ito is highly active in the Purkinje network of the MB, and its inhibition may be the mechanism by which quinidine has a therapeutic effect in these arrhythmias. It must be considered that the effective dose of quinidine may be poorly tolerated and should be cautiously tested in each patient [3,8]. Moreover, lidocaine, propafenone, and amiodarone could be considered in these cases, even though they are rarely effective if administered before catheter ablation [9]. Radiofrequency ablation remains a good therapy that has been shown to effectively suppress Purkinje fiber-triggered ectopy and IVF [34].
Over the past 10 years, some reports have described insufficient pharmacological treatment due to the failure of amiodarone, b-blockers, Magnesium, lidocaine, quinidine, cilostazol, and verapamil [9]. Medical therapy for MB-related VTs is limited. Quinidine may be an effective medical therapy in PVC after catheter ablation. The ablation of PVCs at MB-RV free wall junction led to excellent short- and long-term results, and it should probably be considered as the first-line therapy in these patients to reduce VTs mediated from PF at MB level [32].

6.3. Device Therapy

In cases of sustained VTs/IVF causing cardiac arrest, ICD implantation in secondary prevention is mandatory [23]. Nevertheless, it should be considered to perform catheter ablation and/or administer appropriate medical therapy to reduce or eliminate the number of ICD shocks. There is a lack of reports concerning ICD implantation in primary prevention before and after unsuccessful catheter ablation [33]. The prognosis of MB-related VT/VF without any therapy is uncertain. We do suggest that an invasive therapeutic strategy could be positively performed to prevent malignant arrhythmias and cardiac arrest. It is of valuable importance to consider the long-term impact that ICD implantation may carry in these patients since they are usually middle-aged, particularly when for primary prevention. Indeed, they may experience device-related complications and undergo various generator changes during their lifetime. Subcutaneous ICD (s-ICD) should be preferred because of the absence of a need for pacing. In addition, psychological impact deriving from ICD carrying and possibly from shock occurrence, either appropriate or inappropriate, should be considered as well [35]. For these reasons, the ablation strategy gains an even stronger rationale over device therapy.

6.4. Sports Eligibility and Risk Stratification

There are no specific indications for patients presenting with MB-related arrhythmias regarding lifestyle modification and sport participation. Recommendations for these patients follow those of the latest guidelines on sports cardiology and exercise in patients with cardiovascular diseases [36]. Recommendations are dependent on the clinical presentation of the patient, which has been shown to be highly variable. Therefore, patients with isolated PVCs and NSVT are permitted to participate in competitive and leisure-time sports activities with periodic re-evaluation based on Holter monitoring, 12-lead ECG, exercise test, and echocardiography. High-burden PVCs and NSVT have not been correlated with unfavorable outcomes, even in an asymptomatic pediatric population and without structural heart disease [37]. Continuation of intensive or competitive sports participation in patients with malignant arrhythmias or already implanted with an ICD should undergo shared decision-making, considering the absence of underlying structural disease at risk of progression and the absence of proven correlation of arrhythmias occurrence concomitantly with sports activities. In this setting, non-invasive evaluation could provide unclear results during the sports eligibility assessment. Recently, it has been proposed a comprehensive invasive workflow for the assessment of patients presenting with ventricular arrhythmias [38]. Particularly, electrophysiological study (EPS) and electroanatomical (EAM) mapping could provide important information for risk stratification during the sports eligibility assessment. However, no specific protocol has been reported for the electrophysiological procedures in this context so far. It is assumed that patients with positive EPS for ventricular arrhythmias inducibility or abnormal EAM have a higher risk for sudden cardiac death than those who show negative results at EPS and EAM. In the first case, a catheter ablation procedure and/or s-ICD implantation could be planned. In the meanwhile, it could be reasonable to protect the patient with a temporary solution such as a wearable ICD (w-ICD). On the contrary, patients with negative electrophysiological assessment could undergo only monitoring, ideally with loop recorder implantation, as shown in Figure 4.

6.5. Follow-Up

Patients with asymptomatic PVC/NSVT who have not been referred for a specific treatment should be regularly followed-up, but no specific time lapse between visits has been suggested from recent guidelines. It is reasonable to perform a complete ambulatory visit comprehensive of echocardiogram and a Holter ECG each 6 to 12 months in order to monitor left ventricular ejection fraction for the exclusion of PVC-induced cardiomyopathy and evaluate arrhythmias’ burden. In case of the development of PVC-induced cardiomyopathy or an elevated burden of arrhythmias, specific treatment must be considered, and catheter ablation represents a valid therapeutic option.
Patients who have undergone a specific drug treatment or catheter ablation should be equally followed-up in order to evaluate the efficacy of the chosen treatment, both in terms of symptoms and reduction/suppression of the arrhythmic burden and to exclude possible adverse events. For example, quinidine assumption may lead to overdose, which may present with symptoms linked to the involvement of the central nervous system (i.e., dizziness, headache, nausea, vomiting, hearing, and visual symptoms) or cardiac side effects such as conduction disturbances and proarrhythmic effect. Of note, in case of quinidine overdose, it could be helpful to acidify the patient’s urine to favor excretion.
Finally, patients who presented with a cardiac arrest due to IVF and who have undergone an ICD implantation should be regularly followed up to evaluate arrhythmic relapses and assess the delivery of ICD therapies such as ATP and shocks. For this purpose, it is of particular importance the implementation of a program of remote monitoring, which may promptly lead to an appropriate treatment. In case of recurrent ICD shocks, it is possible to implement a pharmacological therapy, if not present, and perform catheter ablation of the arrhythmic substrate. To conclude, survivors of a cardiac arrest due to IVF could also be referred for genetic counseling, which may identify a potential genetic predisposition to the development of arrhythmias, therefore, help in the prevention process of relatives of the proband.

7. Conclusions

The moderator band is an intracavity structure of the right ventricle with unique anatomical and electrophysiological properties. In fact, the moderator band is composed of two distinct compartments of working myocytes and Purkinje fibers presenting a coaxial configuration, both excitable but electrically uncoupled, because of collagen and lipid droplet insulation. Moreover, they functionally distinguish each other by virtue of different ion channels expression, susceptibility to autonomic system modulation, and mechanical stretch influence, which finally translate into action potential duration gradients and repolarization dispersion. Hence, the conduction system compartment of the moderator band displays an intrinsic dynamic proarrhythmic behavior that needs the muscular compartment in order to initiate ventricular tachycardias. In the setting of the moderator band, structure and function are therefore difficultly discernible, and they ideally resemble two faces of the same coin.

Funding

This research received no external funding.

Institutional Review Board Statement

Not applicable.

Data Availability Statement

Not applicable.

Acknowledgments

Thanks to Alessandra Pescatore (Biosense Webster) for her expertise and support during catheter ablation procedures.

Conflicts of Interest

The authors declare no conflict of interest. All individuals includen in the acknowledgement have consented to be included.

References

  1. Loukas, M.; Klaassen, Z.; Tubbs, R.S.; Derderian, T.; Paling, D.; Chow, D.; Patel, S.; Anderson, R.H. Anatomical observations of the moderator band. Clin. Anat. 2010, 23, 443–450. [Google Scholar] [CrossRef] [PubMed]
  2. Bojsen-Moller, F.; Tranum-Jensen, J. On nerves and nerve endings in the conducting sysetm of the moderator band (septomarginal trabecula). J. Anat. 1971, 108, 387–395. [Google Scholar] [PubMed]
  3. Belhassen, B.; Viskin, S. Idiopathic Ventricular Tachycardia and Fibrillation. J. Cardiovasc. Electrophysiol. 1993, 4, 356–368. [Google Scholar] [CrossRef]
  4. Viskin, S.; Rosso, R.; Rogowski, O.; Belhassen, B. The “Short-Coupled” Variant of Right Ventricular Outflow Ventricular Tachycardia: A Not-So-Benign Form of Benign Ventricular Tachycardia? J. Cardiovasc. Electrophysiol. 2005, 16, 912–916. [Google Scholar] [CrossRef] [PubMed]
  5. Boyden, P.A.; Dun, W.; Robinson, R.B. Cardiac Purkinje fibers and arrhythmias; The GK Moe Award Lecture 2015. Heart Rhythm. 2016, 13, 1172–1181. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  6. Haïssaguerre, M.; Shoda, M.; Jaïs, P.; Nogami, A.; Shah, D.C.; Kautzner, J.; Arentz, T.; Kalushe, D.; Lamaison, D.; Griffith, M.; et al. Mapping and Ablation of Idiopathic Ventricular Fibrillation. Circulation 2002, 106, 962–967. [Google Scholar] [CrossRef]
  7. Haïssaguerre, M.; Shah, D.C.; Jaïs, P.; Shoda, M.; Kautzner, J.; Arentz, T.; Kalushe, D.; Kadish, A.; Griffith, M.; Gaita, F.; et al. Role of Purkinje conducting system in triggering of idiopathic ventricular fibrillation. Lancet 2002, 359, 677–678. [Google Scholar] [CrossRef]
  8. Sadek, M.M.; Benhayon, D.; Sureddi, R.; Chik, W.; Santangeli, P.; Supple, G.E.; Hutchinson, M.D.; Bala, R.; Carballeira, L.; Zado, E.S.; et al. Idiopathic ventricular arrhythmias originating from the moderator band: Electrocardiographic characteristics and treatment by catheter ablation. Heart Rhythm. 2015, 12, 67–75. [Google Scholar] [CrossRef]
  9. Anter, E.; Buxton, A.E.; Silverstein, J.R.; Josephson, M.E. Idiopathic Ventricular Fibrillation Originating from the Moderator Band. J. Cardiovasc. Electrophysiol. 2012, 24, 97–100. [Google Scholar] [CrossRef]
  10. Nogami, A.; Sugiyasu, A.; Kubota, S.; Kato, K. Mapping and ablation of idiopathic ventricular fibrillation from the Purkinje system. Heart Rhythm. 2005, 2, 646–649. [Google Scholar] [CrossRef]
  11. Walton, R.D.; Pashaei, A.; Martinez, M.E.; Constantin, M.; Duchateau, J.; Bear, L.; Cros, C.; Pascarel-Auclerc, C.; Guo, Y.; Benoist, D.; et al. Compartmentalized Structure of the Moderator Band Provides a Unique Substrate for Macroreentrant Ventricular Tachycardia. Circ. Arrhythmia Electrophysiol. 2018, 11, e005913. [Google Scholar] [CrossRef] [PubMed]
  12. Atkinson, A.; Inada, S.; Li, J.; Tellez, J.O.; Yanni, J.; Sleiman, R.; Allah, E.A.; Anderson, R.H.; Zhang, H.; Boyett, M.R.; et al. Anatomical and molecular mapping of the left and right ventricular His–Purkinje conduction networks. J. Mol. Cell. Cardiol. 2011, 51, 689–701. [Google Scholar] [CrossRef] [PubMed]
  13. Lee, J.Y.; Hur, M.S. Morphological classification of the moderator band and its relationship with the anterior papillary muscle. Anat. Cell Biol. 2019, 52, 38–42. [Google Scholar] [CrossRef] [PubMed]
  14. Dobrzynski, H.; Anderson, R.H.; Atkinson, A.; Borbas, Z.; D’Souza, A.; Fraser, J.F.; Inada, S.; Logantha, S.J.; Monfredi, O.; Morris, G.M.; et al. Structure, function and clinical relevance of the cardiac conduction system, including the atrioventricular ring and outflow tract tissues. Pharmacol. Ther. 2013, 139, 260–288. [Google Scholar] [CrossRef]
  15. Sommer, J.R.; Johnson, E.A. Cardiac muscle: A comparative study of Purkinje fibers and ventricular fibers. J. Cell Biol. 1968, 36, 497–526. [Google Scholar] [CrossRef]
  16. Schmid, P.G.; Greif, B.J.; Lund, D.D.; Roskoski, R., Jr. Regional choline acetyltransferase activity in the guinea pig heart. Circ. Res. 1978, 42, 657–660. [Google Scholar] [CrossRef] [Green Version]
  17. Xiao, L.; Koopmann, T.T.; Ördög, B.; Postema, P.G.; Verkerk, A.O.; Iyer, V.; Sampson, K.J.; Boink, G.J.; Mamarbachi, M.A.; Varro, A.; et al. Unique cardiac Purkinje fiber transient outward current β-subunit composition: A potential molecular link to idiopathic ventricular fibrillation. Circ. Res. 2013, 112, 1310–1322. [Google Scholar] [CrossRef]
  18. Myerburg, R.J.; Stewart, J.W.; Hoffman, B.F. Electrophysiological Properties of the Canine Peripheral A-V Conducting System. Circ. Res. 1970, 26, 361–378. [Google Scholar] [CrossRef] [Green Version]
  19. He, B.; Lu, Z.; He, W.; Huang, B.; Yu, L.; Wu, L.; Cui, B.; Hu, X.; Jiang, H. The effects of atrial ganglionated plexi stimulation on ventricular electro-physiology in a normal canine heart. J. Interv. Card. Electrophysiol. 2013, 37, 1–8. [Google Scholar] [CrossRef]
  20. Antzelevitch, C.; Sicouri, S. Clinical relevance of cardiac arrhythmias generated by afterdepolarizations: Role of M cells in the generation of U waves, triggered activity and torsade de pointes. J. Am. Coll. Cardiol. 1994, 23, 259–277. [Google Scholar] [CrossRef] [Green Version]
  21. Li, P.; Rudy, Y. A model of canine purkinje cell electrophysiology and Ca(2+) cycling: Rate dependence, triggered activity, and comparison to ventricular myocytes. Circ. Res. 2011, 109, 71–79. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  22. Quinn, T.A.; Jin, H.; Lee, P.; Kohl, P. Mechanically Induced Ectopy via Stretch-Activated Cation-Nonselective Channels Is Caused by Local Tissue Deformation and Results in Ventricular Fibrillation if Triggered on the Repolarization Wave Edge (Commotio Cordis). Circ. Arrhythmia Electrophysiol. 2017, 10, e004777. [Google Scholar] [CrossRef] [PubMed]
  23. Zeppenfeld, K.; Tfelt-Hansen, J.; de Riva, M.; Winkel, B.G.; Behr, E.R.; Blom, N.A.; Charron, P.; Corrado, D.; Dagres, N.; de Chillou, C.; et al. 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur. Heart J. 2022, 43, 3997–4126. [Google Scholar]
  24. Steinfurt, J.; Nazer, B.; Aguilar, M.; Moss, J.; Higuchi, S.; Zarse, M.; Trolese, L.; Gressler, A.; Faber, T.S.; Odening, K.E.; et al. Catheter ablation of short-coupled variant of torsade de pointes. Clin. Res. Cardiol. 2021, 111, 502–510. [Google Scholar] [CrossRef] [PubMed]
  25. Crawford, T.; Mueller, G.; Good, E.; Jongnarangsin, K.; Chugh, A.; Pelosi, F.; Ebinger, M.; Oral, H.; Morady, F.; Bogun, F. Ventricular arrhythmias originating from papillary muscles in the right ventricle. Heart Rhythm. 2010, 7, 725–730. [Google Scholar] [CrossRef]
  26. Enriquez, A.; Baranchuk, A.; Briceno, D.; Saenz, L.; Garcia, F. How to use the 12-lead ECG to predict the site of origin of idiopathic ventricular arrhythmias. Heart Rhythm. 2019, 16, 1538–1544. [Google Scholar] [CrossRef]
  27. Efremidis, M.; Vlachos, K.; Kyriakopoulou, M.; Mililis, P.; Martin, C.A.; Bazoukis, G.; Dragasis, S.; Megarisiotou, A.; Unger, P.; Frontera, A.; et al. The RV1-V3 transition ratio: A novel electrocardiographic criterion for the differentiation of right versus left outflow tract premature ventricular complexes. Heart Rhythm. O2 2021, 2, 521–528. [Google Scholar] [CrossRef]
  28. Fries, B.; Johnson, V.; Rutsatz, W.; Schmitt, J.; Bogossian, H. Lokalisation ventrikulärer Extrasystolen im 12-Kanal-EKG [Localization of ventricular premature contractions by 12-lead ECG]. Herzschrittmachertherapie Elektrophysiologie 2021, 32, 21–26. [Google Scholar] [CrossRef]
  29. Santoro, F.; Di Biase, L.; Hranitzky, P.; Sanchez, J.E.; Santangeli, P.; Perini, A.P.; Burkhardt, J.D.; Natale, A. Ventricular Tachycardia Originating from the Septal Papillary Muscle of the Right Ventricle: Electrocardiographic and Electrophysiological Characteristics. J. Cardiovasc. Electrophysiol. 2014, 26, 145–150. [Google Scholar] [CrossRef]
  30. Chen, H.; Shi, L.; Yang, B.; Ju, W.; Zhang, F.; Yang, G.; Gu, K.; Li, M.; Cao, K.; Ouyang, F.; et al. Electrophysiological Characteristics of Bundle Branch Reentry Ventricular Tachycardia in Patients Without Structural Heart Disease. Circ. Arrhythmia Electrophysiol. 2018, 11, e006049. [Google Scholar] [CrossRef]
  31. Chinitz, J.S.; Sedaghat, D.; Harding, M.; Darge, A.; Epstein, L.M.; John, R. Adjuvant use of a cryoballoon to facilitate ablation of premature ventricular contraction–triggered ventricular fibrillation originating from the moderator band. Heart Case Rep. 2019, 5, 578–581. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  32. Li, Y.-Q.; Wang, Y.-X.; Que, D.-D.; Shao, J.; Song, X.-D.; Yang, P.-Z. Successful Ablation of Moderator Band-Originated Ventricular Tachycardia at Its Ventricle Insertion Sites. Chin. Med. J. 2018, 131, 1371–1372. [Google Scholar] [CrossRef] [PubMed]
  33. Li, J.-Y.; Jiang, J.-B.; He, Y.; Luo, J.-C.; Zhong, G.-Q. Ventricular Tachycardia Originating from Moderator Band: New Perspective on Catheter Ablation. Case Rep. Cardiol. 2017, 2017, 3414360. [Google Scholar] [CrossRef]
  34. Serdoz, L.V.; Rittger, H.; Furlanello, F.; Bastian, D. Quinidine—A legacy within the modern era of antiarrhythmic therapy. Pharmacol. Res. 2019, 144, 257–263. [Google Scholar] [CrossRef] [PubMed]
  35. Fumagalli, S.; Pieragnoli, P.; Haugaa, K.H.; Potpara, T.S.; Rasero, L.; Ramacciati, N.; Ricciardi, G.; Solimene, F.; Mascia, G.; Mascioli, G.; et al. The influence of age on the psychological profile of patients with cardiac implantable electronic devices: Results from the Italian population in a multicenter study conducted by the European Heart Rhythm Association. Aging Clin. Exp. Res. 2018, 31, 1219–1226. [Google Scholar] [CrossRef]
  36. Pelliccia, A.; Sharma, S.; Gati, S.; Bäck, M.; Börjesson, M.; Caselli, S.; Collet, J.-P.; Corrado, D.; Drezner, J.A.; Halle, M.; et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur. Heart J. 2021, 42, 17–96, Erratum in Eur. Heart J. 2021, 42, 548–549. [Google Scholar] [CrossRef]
  37. Porcedda, G.; Brambilla, A.; Favilli, S.; Spaziani, G.; Mascia, G.; Giaccardi, M. Frequent Ventricular Premature Beats in Children and Adolescents: Natural History and Relationship with Sport Activity in a Long-Term Follow-Up. Pediatr. Cardiol. 2019, 41, 123–128. [Google Scholar] [CrossRef]
  38. Russo, A.D.; Compagnucci, P.; Casella, M.; Gasperetti, A.; Riva, S.; Dessanai, M.A.; Pizzamiglio, F.; Catto, V.; Guerra, F.; Stronati, G.; et al. Ventricular arrhythmias in athletes: Role of a comprehensive diagnostic workup. Heart Rhythm. 2021, 19, 90–99. [Google Scholar] [CrossRef]
Figure 1. Morphology of premature ventricular complexes originating from (1) inferior tricuspid valve, (2) moderator band, (3) left posterior fascicle, and (4) moderator band (note DII/DIII discordance). SN: Sinus Node; AVN: atrio-ventricular node; RB right bundle; LB: left bundle; BF: Bachmann’s fibers.
Figure 1. Morphology of premature ventricular complexes originating from (1) inferior tricuspid valve, (2) moderator band, (3) left posterior fascicle, and (4) moderator band (note DII/DIII discordance). SN: Sinus Node; AVN: atrio-ventricular node; RB right bundle; LB: left bundle; BF: Bachmann’s fibers.
Jcdd 10 00159 g001
Figure 2. (a) Intracardiac echocardiography view; IP is in the right atrium in the right anterior oblique view; green lines paint the long and short axis of RV, constructing a 3D RV echo–map. (b) same image in the left anterior oblique view; (c) two−dimensional view of RV. The green lines trace the endocardial surface, and yellow lines the MB; (d) Merge of the 3D echo map and activation map of PVC in lateral view; (e) PVC activation map in right anterior oblique view; ablation at the earliest activation site on the MB using an electroanatomic mapping system; the red color on the activation map is the earliest activation site; the red bullets are the RF lesion tagged points; (f) electrogram PVC potential; sharp and QS unipolar signal and adequate PVC anticipation. IP: intracardiac probe; RV: right ventricle; MB: moderator band; 3D: three dimensional; PVC: premature ventricular complex; RF: radiofrequency.
Figure 2. (a) Intracardiac echocardiography view; IP is in the right atrium in the right anterior oblique view; green lines paint the long and short axis of RV, constructing a 3D RV echo–map. (b) same image in the left anterior oblique view; (c) two−dimensional view of RV. The green lines trace the endocardial surface, and yellow lines the MB; (d) Merge of the 3D echo map and activation map of PVC in lateral view; (e) PVC activation map in right anterior oblique view; ablation at the earliest activation site on the MB using an electroanatomic mapping system; the red color on the activation map is the earliest activation site; the red bullets are the RF lesion tagged points; (f) electrogram PVC potential; sharp and QS unipolar signal and adequate PVC anticipation. IP: intracardiac probe; RV: right ventricle; MB: moderator band; 3D: three dimensional; PVC: premature ventricular complex; RF: radiofrequency.
Jcdd 10 00159 g002
Figure 3. (a) Basal Electrogram and PVC; (b) Ventricular tachycardia; (c) Identification of Purkinje fiber potential during catheter ablation of premature ventricular complex originating from moderator band. Purkinje fiber potential is represented by a sharp, short-lasting, high-frequency potential and prepotential; (d) ventricular tachycardia during RF.
Figure 3. (a) Basal Electrogram and PVC; (b) Ventricular tachycardia; (c) Identification of Purkinje fiber potential during catheter ablation of premature ventricular complex originating from moderator band. Purkinje fiber potential is represented by a sharp, short-lasting, high-frequency potential and prepotential; (d) ventricular tachycardia during RF.
Jcdd 10 00159 g003
Figure 4. Comprehensive list of examinations and therapeutic strategies available for the management of patients with MB-related ventricular arrhythmias. EPS: electrophysiological study; electrophysiological mapping; sVA: sustained ventricular tachycardia; SICD: subcutaneous implantable defibrillator; W-ICD: wearable ICD; ILR: implantable loop recorder; CA: catheter ablation.
Figure 4. Comprehensive list of examinations and therapeutic strategies available for the management of patients with MB-related ventricular arrhythmias. EPS: electrophysiological study; electrophysiological mapping; sVA: sustained ventricular tachycardia; SICD: subcutaneous implantable defibrillator; W-ICD: wearable ICD; ILR: implantable loop recorder; CA: catheter ablation.
Jcdd 10 00159 g004
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Landra, F.; Marallo, C.; Santoro, A.; Taddeucci, S.; Tavera, M.C.; Baiocchi, C.; Palazzuoli, A. Moderator Band and Ventricular Tachycardia: Structural or Functional Substrate? J. Cardiovasc. Dev. Dis. 2023, 10, 159. https://doi.org/10.3390/jcdd10040159

AMA Style

Landra F, Marallo C, Santoro A, Taddeucci S, Tavera MC, Baiocchi C, Palazzuoli A. Moderator Band and Ventricular Tachycardia: Structural or Functional Substrate? Journal of Cardiovascular Development and Disease. 2023; 10(4):159. https://doi.org/10.3390/jcdd10040159

Chicago/Turabian Style

Landra, Federico, Carmine Marallo, Amato Santoro, Simone Taddeucci, Maria Cristina Tavera, Claudia Baiocchi, and Alberto Palazzuoli. 2023. "Moderator Band and Ventricular Tachycardia: Structural or Functional Substrate?" Journal of Cardiovascular Development and Disease 10, no. 4: 159. https://doi.org/10.3390/jcdd10040159

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop